A national responsibility / Civic Sovereignty Party
Life-Saving Care for U.S. Citizens
Life-saving care should be within reach.
CSP’s proposal to ensure U.S. citizens can access medically necessary life-saving medicines and procedures, with an income-based annual patient limit and a public funding backstop.
Policy proposal — patient-cost model is illustrative
The access commitment is the policy goal. Eligibility details, patient-payment settings, clinical administration, and the funding plan remain for review.
On this page
- A national responsibility to protect life
- Who and what the proposed benefit covers
- Care first, with affordable payment afterward
- A sourced example of an income-based annual limit
- Patient payments and program funding are different questions
- Making access real in practice
- Existing emergency rights remain in place
- Sources, assumptions, and decisions for review
Citizen care and shared responsibility
A national responsibility to protect life
The United States has a responsibility to its people. CSP believes medically necessary life-saving drugs and procedures should always be accessible to U.S. citizens, with a person’s ability to pay determining an affordable contribution rather than whether essential care is received.
The proposal builds on the life-and-choice support framework: protect individual choice, remove financial barriers, and give the commitment to life a practical funding and delivery system. This broader package would cover recurring medicines and procedures, so the patient-payment model uses an annual limit instead of charging a new full fee for every prescription or treatment.
This is a proposed citizen benefit and an illustrative financing design. It is not an operating CSP health program or a claim that every element of the package has already been costed or enacted.
Citizen care and shared responsibility
Who and what the proposed benefit covers
The legislation must define eligible services, safe and effective treatment standards, and the process for disputed coverage. The access goal does not mean an entitlement to an unsafe or clinically inappropriate intervention.
The citizen eligibility rule also requires careful treatment of U.S. nationals, including people in American Samoa, alongside CSP’s territorial-equality commitment. Nationality and citizenship must not be treated as interchangeable legal terms.
- U.S. citizens living in the states, District of Columbia, and U.S. territories would be within the stated access commitment.
- Covered medicines and procedures would be medically necessary to prevent death or a life-threatening deterioration, using evidence-based clinical criteria.
- Ongoing treatment can be life-saving even when the patient is not in immediate emergency distress.
- Qualified clinicians would assess medical need, with an independent clinical appeal and an urgent pathway where delay would threaten life.
- Existing insurance and public coverage would be coordinated before the new program pays the remaining covered obligation.
Citizen care and shared responsibility
Care first, with affordable payment afterward
Urgent clinical assessment and treatment should proceed without waiting for income documents, an upfront payment, or an administrative coverage dispute. A participating-provider network and public backstop would have to arrange clinically appropriate care or a safe referral when the first provider cannot deliver it.
Low-income citizens would have a $0 contribution under the example model below. Other covered households would have an income-scaled annual limit, with hardship waivers and manageable, interest-free payment arrangements when needed. Inability to pay should not become a reason to withhold the life-saving care.
Citizenship, insurance, and income checks would use a defined, privacy-conscious process. They should not become a barrier to emergency treatment. Provider payment, capacity, supply continuity, and appeals would need enforceable standards.
Citizen care and shared responsibility
A sourced example of an income-based annual limit
The following is a hypothetical model for discussion, using published government inputs and clearly identified policy choices. It is not a final fee schedule. The annual limit applies across covered life-saving medicines and procedures for the covered household; it is not charged once per procedure or prescription.
The patient would pay the lesser of the remaining covered patient charges and the annual limit, subject to a further hardship waiver. A household with no covered patient charges would not automatically owe the calculated limit.
ILLUSTRATIVE ANNUAL LIMIT — NOT FINAL POLICY
Let I be verified annual gross household income and P the published 2026 HHS poverty guideline for household size and region. This example protects income through 2P, applies 1% to income above that floor, rounds to the nearest $25, and caps the annual household amount at $2,100.
Annual limit = min($2,100, $25 × floor([0.01 × max(0, I − 2P)] / $25 + 0.5)). Actual patient payments are limited to remaining covered patient charges and may be reduced further for hardship.
The 2026 HHS notice supplies P: for a four-person household, $33,000 in the contiguous states and D.C., $41,250 in Alaska, or $37,950 in Hawaii. Territorial application requires an approved benchmark; an unresolved benchmark should not delay urgent care.
The 2026 Medicare Part D announcement supplies the $2,100 drug-benefit benchmark. Using that figure as a household ceiling across medicines and procedures is a proposed extension, not current Medicare coverage or a published price for this program.
| Verified income example | Raw 1% above $66,000 | Illustrative annual limit |
|---|---|---|
| $49,500 | $0 | $0 |
| $66,000 | $0 | $0 |
| $82,500 | $165 | $175 |
| $87,460 | $214.6 | $225 |
| $99,000 | $330 | $325 |
| $132,000 | $660 | $650 |
| $165,000 | $990 | $1,000 |
| $198,000 | $1,320 | $1,325 |
| $264,000 | $1,980 | $1,975 |
| $330,000 | $2,640 | $2,100 |
The $87,460 row uses the Census’s overall 2025 median household income as an input for an assumed four-person household. Calculation: 1% × ($87,460 − $66,000) = $214.60; rounding gives a $225 annual limit. This is not a reported median specifically for four-person households.
The $0 tier is based on income. Lack of insurance does not block the proposed citizen benefit, and additional hardship relief would protect citizens who cannot pay the calculated amount. The administrative definition of a household, partial-year rules, waivers, territory benchmarks, and payment schedules remain for review.
Citizen care and shared responsibility
Patient payments and program funding are different questions
The broader care commitment could require substantially more public funding than a birth-only package, but a reliable comparison needs the covered population, services, utilization, and prices. A higher provider cost does not by itself establish that patients can afford a higher fee.
CMS reports total U.S. health spending of $5.3 trillion in 2024, including $1,634.7 billion for hospitals and $467.0 billion for retail prescription drugs. Those are broad national, all-payer totals—not a cost estimate for this narrower citizen proposal. CMS National Health Expenditure fact sheet.
A costed plan needs eligible-citizen counts, service-specific utilization, negotiated allowed prices, existing insurer and public-program payments, likely patient contributions, administrative costs, and provider capacity. It must avoid counting the same expense twice across existing coverage and the new program.
- Estimate payments for covered care remaining after other coverage.
- Add administration, appeals, capacity needs, and transition costs.
- Subtract expected patient contributions, including the effect of waivers.
- Compare against the public spending that the proposal would replace or redirect.
- Identify appropriations and any new revenue before claiming the package is funded.
Citizen care and shared responsibility
Making access real in practice
The implementation plan should measure access delays, interruption of necessary treatment, avoidable billing disputes, waiver decisions, and the program’s actual public cost. It should report results without exposing patients’ private medical information.
- A dependable network of participating hospitals, pharmacies, clinicians, and referral services.
- Negotiated provider payment and medicine purchasing, with transparent cost and availability monitoring.
- Prompt reimbursement so access does not depend on providers absorbing undefined costs.
- Independent clinical review, rapid appeals, and protection against unnecessary delay.
- Supply and continuity plans for recurring medicines and treatments.
- Coordination with birth-care relief and existing coverage to prevent duplicate billing for overlapping services.
Citizen care and shared responsibility
Existing emergency rights remain in place
CMS explains that, in covered hospital emergency departments, EMTALA protects medical screening and stabilizing treatment regardless of insurance, ability to pay, or U.S. citizenship. CMS emergency-room rights guidance.
This proposed citizen benefit would add a financing and access commitment for covered life-saving care. It would not remove existing emergency-treatment obligations for other patients.
Citizen care and shared responsibility
Sources, assumptions, and decisions for review
The 200% income floor, 1% rate, $25 rounding, household-wide annual structure, and extension of the $2,100 benchmark to procedures are proposed design choices. The sources do not establish that those choices are affordable, sufficient, or fiscally sustainable.
Final eligibility definitions, benefits, territorial income benchmarks, provider-payment rates, hardship rules, annual administration, citizenship verification, financing, and the clinical appeals process require further policy decisions. Research checked October 28, 2026.
- HHS 2026 poverty guidelines: household-size and regional income inputs.
- CMS 2026 Medicare Part D announcement: the $2,100 drug-benefit out-of-pocket threshold used only as a benchmark for the illustrative ceiling.
- Census, Income in the United States: 2025: a published income figure used in the worked example.
- CMS national expenditure data: context for scale, not a score of this proposal.
- CMS EMTALA guidance: the existing emergency-care baseline.
Common questions
Would every U.S. citizen be eligible regardless of income?
The proposed access commitment is for U.S. citizens across incomes. Income determines the proposed patient contribution, with a $0 tier and hardship waivers. Medical need and the final benefit definitions determine which services are covered.
Would uninsured citizens be denied care?
No. Lack of insurance would not disqualify an otherwise eligible citizen from the proposed program. Existing coverage is coordinated when it exists; the public backstop and income-based contribution protect access when it does not.
Is the $2,100 ceiling a current limit on all medicines and procedures?
No. It is a published 2026 Medicare Part D drug-benefit benchmark. Applying that ceiling to a proposed citizen program covering procedures as well as medicines is an illustrative policy choice.
Would each new treatment trigger another full fee?
The example uses one annual household limit across covered care. Patient payments for covered services accumulate toward that limit; the full calculated amount is not charged separately for each treatment.
Does this page claim the program is already funded?
No. It identifies the access goal, an illustrative patient-cost model, and the information needed for a credible cost and funding plan.
Connected proposals